NHS says 'call 999' if you spot this hot weather symptom on skin
The NHS has issued a warning to Brits, urging them to "call 999 now" if they observe a potentially severe symptom of hot weather on their skin. As the UK endures soaring temperatures this summer, it's vital to be vigilant for any indications of heatstroke.
According to the NHS, without immediate intervention, heat exhaustion can rapidly progress into heatstroke. "Heat exhaustion does not usually need emergency medical help if you can cool down within 30 minutes," stated the health organisation.
"If it turns into heatstroke, it needs to be treated as an emergency." The NHS website cautions that you should "call 999 now if you or someone else have signs of heatstroke".
A primary sign is skin that feels hot but isn't perspiring and may appear red. The NHS points out that this symptom might be harder to identify on brown and black skin.
Emergency aid should also be sought if a person continues to feel unwell after 30 minutes of resting in a cool place, receiving cooling treatment, and hydrating. Other symptoms of heatstroke that necessitate immediate 999 assistance include:
An extremely high temperature
Rapid pulse
Fast breathing or difficulty breathing
Confusion and poor coordination
Seizure or fit
Loss of consciousness
"Put the person in the recovery position if they lose consciousness while you're waiting for help," advises the NHS. Before escalating to heatstroke, the warning signs of heat exhaustion to look out for include:
Fatigue
Light-headedness
Head pain
Nausea or vomiting
Muscular cramps in the limbs and abdomen
Profuse perspiration with skin becoming pallid and clammy or developing heat rash
Rapid respiration or pulse
Elevated body temperature
Intense thirst
General weakness
The NHS stated: "The symptoms of heat exhaustion are often the same in adults and children, although children may become irritable too."
What to do if someone has symptoms
As reported by Surrey Live, if someone you know is displaying signs of heat exhaustion, they need to be cooled down immediately and given fluids. The NHS advises following these four essential steps:
Move them to a cool place
Remove all unnecessary clothing like a jacket or socks
Get them to drink a sports or rehydration drink, or cool water
Cool their skin – spray or sponge them with cool water and fan them. Cold packs, wrapped in a cloth and put under the armpits or on the neck are good too
You should remain with them until they recover, which ought to take 30 minutes. Nevertheless, if this approach proves unsuccessful you may need to call 999.
Preventing heatstroke
"There's a high risk of heat exhaustion or heatstroke during hot weather or exercise," the NHS says. To help prevent heat exhaustion or heatstroke the health body recommends you:
Drink more cold drinks, especially if you're active or exercising
Wear light-coloured, loose clothing
Avoid the sun between 11am and 3pm
Avoid excess alcohol
Avoid extreme exercise
If you're inside on a very hot day, close curtains, close windows if it's hotter outside than in your home and turn off electrical equipment and lights that get hot.
This will also prevent dehydration and help your body keep itself cool.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
40 minutes ago
- The Independent
Warning issued to patients after using weight-loss jabs
Health chiefs have raised concerns about patients regaining weight after stopping popular weight-loss drugs such as Wegovy and Mounjaro, calling for robust support to prevent them from piling on the pounds again. The National Institute for Health and Care Excellence (Nice), the UK's health watchdog, highlighted research indicating that many individuals regain weight if not adequately supported after ceasing treatment. Nice stressed that those coming off the drugs should be offered "structured advice and follow-up support" to mitigate weight gain. This guidance specifically applies to individuals receiving these treatments through the NHS. However, an estimated 1.5 million people in the UK are currently using weight-loss injections, with the vast majority paying privately. These individuals will not be eligible for NHS support once their treatment concludes. Over the next three years, approximately 240,000 people deemed to have the "greatest need" are anticipated to receive Mounjaro, also known as tirzepatide, via the NHS. The new 'quality standard' from Nice says that NHS patients should be monitored for at least a year after they complete treatment, and extra support should be offered if needed. It emphasises building 'long-term behavioural habits, use self-monitoring tools, and draw on wider support – from online communities to family-led interventions and local activities'. This standard, a type of guidance for the health services in England and Wales, sets out expectations for health providers including how they should support patients. 'Successful weight management doesn't end when medication stops or when someone completes a behavioural programme,' said Professor Jonathan Benger, deputy chief executive and chief medical officer at Nice. 'We know that the transition period after treatment is crucial, and people need structured support to maintain the positive changes they've made. 'This new standard makes sure services provide that vital continuity of care, and it supports the NHS 10 Year Plan to shift from a 'sickness service' to a genuine health service focused on prevention.' Dr Rebecca Payne, chair of Nice's Quality Standards Advisory Committee, added: 'Weight management is a long-term journey, not a short-term fix. 'The evidence is clear that advice and support for maintaining weight after stopping medicines or completing behavioural interventions can help prevent weight regain and enable people to experience lasting benefits. 'We've seen excellent examples of services that already provide comprehensive discharge planning and ongoing support. 'This quality standard will help ensure all healthcare providers adopt these best practices, giving every person the best chance of maintaining their weight management success over the long term. 'This standard ensures healthcare services are equipped to provide that essential ongoing support.' Commenting, Henry Gregg, chief executive of the National Pharmacy Association, said: ' Pharmacies take their responsibilities seriously to provide full wrap around support to patients trying to achieve a healthy weight. 'We know that although medication can be effective in speeding up weight loss in some people, it is not a silver bullet and patients need to make long term lifestyle changes to make their weight loss sustainable. 'The current NHS roll out of weight loss treatment is very small, with only a handful of patients receiving it and it will continue to be the case that the vast majority of eligible patients will be seen by their pharmacy.' Professor Kamila Hawthorne, chairwoman of the Royal College of GPs, said: 'There is no one-size-fits-all approach to tackling obesity – what works for one patient will likely not work for another and, as with any medication, weight-loss drugs do not come without risk. 'It's also the case that patients will likely need support to sustain their weight loss once they stop taking the medication. As such, this is important and sensible guidance from Nice. 'As a college, we've been clear that whilst weight loss medications have significant potential benefits for patients who are struggling to lose weight, they mustn't be seen as a 'silver bullet' and ensuring access to sufficient 'wraparound' services – particularly for when patients come off their medication – will be key to optimal health outcomes.'
The Independent
40 minutes ago
- The Independent
Urgent warning over virus dangerous to newborns as cases surge abroad
Health experts say the UK should brace for a surge in a potentially serious virus following a record number of cases in Australia. NHS officials said that the Australian winter is often a good predictor of how viruses will spread in England. In Australia, respiratory syncytial virus (RSV) cases have surged in recent months, and officials have said that cases have been steadily increasing in England since the start of 2025. NHS England has urged pregnant women to get the vaccine, which protects against RSV, in order to protect their newborn babies. The virus is a leading cause of death among babies and the main cause of hospital admissions for children. Kate Brintworth, chief midwifery officer for NHS England, said that while for most adults, RSV 'only causes mild, cold-like symptoms, for older adults and young children, it can lead to serious breathing problems that can end up in hospitalisation'. 'Getting vaccinated while pregnant is the best way to protect your baby from the moment they are born, and now is the time for mums to act, to make sure their babies are protected ahead of their first few months this winter, when there tends to be more bugs circulating.' Pregnant women can get the jab from 28 weeks of pregnancy onwards through their maternity services or GP surgery. Older adults aged 75-79 are also eligible for the jab, and NHS England will start inviting people to come forward in the next few weeks. Symptoms of an RSV infection NHS RSV is a common cause of coughs and colds, but some people have a high risk of getting seriously ill from the virus, including babies and adults over the age of 75. In babies, RSV is a common cause of a type of chest infection called bronchiolitis. Last week, the UK Health Security Agency published data showing the efficacy of the vaccine. It said that the jab for pregnant women can prevent 72 per cent of hospital admissions for their babies. And the vaccine is 82 per cent effective at preventing hospital admissions for RSV among older adults, UKHSA said.
Scottish Sun
41 minutes ago
- Scottish Sun
Thousands of Brits urged to ‘get vaccinated now' to protect against killer bug often mistaken for a cold
Each year RSV kills around 8,000 people in the UK and hospitalises tens of thousands more. LIFE-SAVER Thousands of Brits urged to 'get vaccinated now' to protect against killer bug often mistaken for a cold Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) THOUSANDS of Brits are being urged to take up a jab that protects against a sometimes deadly "cold-like" virus. The vaccine for respiratory syncytial virus (RSV) is offered to pregnant mum's to protect unborn babies from the disease expected to surge in the coming months. Sign up for Scottish Sun newsletter Sign up 1 Pregnant women can get the jab from 28 weeks of pregnancy RSV is a common infection, which in the majority of people, just causes mild, flu-like symptoms, similar to the common cold. It can, on occasion, lead to chest infections like bronchiolitis and pneumonia, especially in newborns and the elderly. Each year it kills around 8,000 people in the UK and hospitalises tens of thousands more. Experts think the UK should brace for a surge this autumn, when the disease typically rears its head, following a record number of cases in Australia. NHS officials said that the Australian winter is often a good predictor of how viruses will spread in England. And following a surge in cases number of RSV cases in Australia, officials have said that cases have been steadily increasing in England since the start of 2025. NHS England has urged pregnant women to get the RSV vaccine to protect their babies, as the virus is a leading cause of infant deaths and the top reason for hospital admissions in young children. Kate Brintworth, chief midwifery officer for NHS England, said: "While for most adults RSV only causes mild, cold-like symptoms, for older adults and young children it can lead to serious breathing problems that can end up in hospitalisation. "Getting vaccinated while pregnant is the best way to protect your baby from the moment they are born, and now is the time for mums to act, to make sure their babies are protected ahead of their first few months this winter, when there tends to be more bugs circulating." Pregnant women can get the jab from 28 weeks of pregnancy onwards through their maternity services or GP surgery. RSV vaccine Older adults aged 75-79 are also eligible for the jab and NHS England will start inviting people to come forward in the next few weeks. Last week, the UK Health Security Agency (UKHSA) published data showing the efficacy of the vaccine, which was first rolled out in summer 2024. It said that the jab for pregnant women can prevent 72 per cent of hospital admissions for their babies. The antibodies the mums produce in response to the jab are passed to their babies in the womb, protecting them for the first six months after being born. And the vaccine is 82 per cent effective at preventing hospital admissions for RSV among older adults, UKHSA said. Higher risk babies can receive the nirsevimab vaccine from September – with the single jab replacing five monthly injections previously given to infants classed as being at high risk. It will protect them against RSV which is even more serious in high-risk infants. Around 7,000 babies will be eligible and get about 80 per cent protection for six months from a single injection. The previous weekly treatment was only 55 per cent effective.
